Posts in category

PDL


In the second instalment of a series of webinars entitled Understanding Your Risk Capacity, Nicolette Ellis, Gary West, and Dr Brett MacFarlane continue their discussions about measuring, evaluating, and managing …

Mixups with varicella vaccines have been reported to PDL lately, especially confusion between chickenpox and shingles jabs PDL has recently received several incident reports where the incorrect varicella vaccine has …

In its latest practice update, PDL lists the medicines most commonly associated with incident reports it receives… and some should be no surprise It is no surprise that the top …

In its latest practice update, PDL has offered information on Schedule 8 medicines management Schedule 8 medicines, in particular opioids, are often involved in notifications to PDL. An Australian Institute …

In this latest practice alert, PDL reviews lapsed PI renewal and other ‘relevant events’ that pharmacists and pharmacy students need to notify Ahpra about Lapsed Professional Indemnity insurance arrangements – …

In this latest PDL Practice Alert, two representatives share some common questions from accredited pharmacists and their responses PDL representatives Gilbert Yeates (Qld Director) and Gary West (Professional Officer and …

PDL has issued a practice alert in which it gives advice on dealing with vaccine requests, particularly given growing demand for flu jabs The recent surge in demand for influenza …

What you need to know about vaccinating against influenza and providing COVID-19 winter doses and boosters As winter approaches, pharmacies will be very busy providing vaccinations against influenza (flu) as …

Ensuring you are covered for incidents such as dispensing errors, vaccinations, incorrect clinical advice, statutory and/or regulatory complaints Professional Indemnity Insurance (PI insurance or PII) may seem like an uninteresting …

Now that the Moderna Spikevax vaccine has been approved for children 6-11 years, PDL has offered members some advice The ATAGI approval of Moderna Spikevax for the primary vaccination of …

PDL has reminded pharmacists that every private prescription presented for potent opioids should be treated with high suspicion. In its latest practice alert, PDL has highlighted the issue of private fentanyl and other …

PDL outlines preparation and risk management considerations for the paediatric Pfizer vaccine The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered by pharmacists from …